National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$59.95
add to cart

Rights & Permissions

topleft topright

Dietary Supplements: A Framework for Evaluating Safety (2005)
Institute of Medicine (IOM)

Citation Manager

. "6 Categories of Scientific Evidence--Information About Related Substances." Dietary Supplements: A Framework for Evaluating Safety. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
194
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Dietary Supplements: A Framework for Evaluating Safety

Primary Genera of Concern

Family

Compounds and Compound

Classes Implicated in Toxicity

Ligustrum

Oleaceae

Unknown

Lobelia

Campanulaceae

Piperidine alkaloids

Lolium

Poaceae

Ergot alkaloidsc

Penitrem alkaloidsc

Selenium accumulation (Selenium is acquired from Seleniferous soils, not funga)

Lupinus

Fabaceae

Quinolizidine alkaloids

Lycopersiconb

Solanaceae

Steroidal alkaloids

Polyhydroxy alkaloids (calystegines)

Lyonia

Ericaceae

Lyoniatoxin

Macrozamia

Zamiaceae

Methyl azoxymethanol glycosides (i.e., macrozamin)

Manihotb

Euphorbiaceae

Cyanogenic glycosides

Melilotusb

Fabaceae

Dicoumarol

Myristicab

Myristicaceae

Safrole

Narcissus

Amaryllidaceae

Isoquinoline alkaloids

Nerium

Apocynaceae

Cardiac glycosides

Nicotiana

Solanaceae

Nicotine alkaloids

Nolina

Liliaceae

Unknown

Ornithogalum

Liliaceae

Colchicine

Oxytropis

Fabaceae

Polyhydroxy alkaloids (swainsonine)

Pachyrhizusb

Fabaceae

Unknown

Packera

Asteraceae

Pyrrolizidine alkaloids

Papaver

Papaveraceae

Isoquinoline alkaloids

Morphinan alkaloids

Pedicularis

Scrophulariaceae

Pyrrolizidine alkaloids

Petasites

Asteraceae

Pyrrolizidine alkaloids

Phaseolusb

Fabaceae

Cyanogenic glycoside (phaseolunatin)

Page
194
Front Matter (R1-R20)
Executive Summary (1-18)
1 Introduction and Background (19-42)
2 Approaches Used by Others and Existing Safety Frameworks (43-84)
3 The Framework (85-125)
4 Categories of Scientific Evidence--Human Information and Data (126-155)
5 Categories of Scientific Evidence--Animal Data (156-174)
6 Categories of Scientific Evidence--Information About Related Substances (175-216)
7 Categories of Scientific Evidence--In Vitro Data (217-234)
8 Interactions (235-246)
9 Vulnerable Groups and Prevalance of Use (247-252)
10 Scientific Principles for Integrating and Evaluating the Available Data (253-268)
11 Applying the Framework: Case Studies Using the Prototype Safety Monographs (269-291)
12 Factors Influencing Use of the Safety Framework (292-296)
13 Findings and Recommendations (297-306)
Appendix A: Existing Frameworks or Systems for Evaluating the Safety of Other Substances (307-315)
Appendix B: Scope of Work and Comments to Initial July 2002 Framework (316-321)
Appendix C: Plant Family Information (322-355)
Appendix D: Chaparral: Prototype Monograph Summary (356-362)
Appendix E: Glucosamine: Prototype Monograph Summary (363-366)
Appendix F: Melatonin: Prototype Monograph Summary (367-371)
Appendix G: Chromium Picolinate: Prototype Monograph Summary (372-375)
Appendix H: Saw Palmetto: Prototype Monograph Summary (376-379)
Appendix I: Shark Cartilage: Prototype Monograph Summary (380-384)
Appendix J: Prototype Focused Monograph: Review of Liver-Related Risks for Chaparral (385-449)
Appendix K: Protoype Focused Monograph: Review of Anti-Androgenic Risks of Saw Palmetto Ingestion by Women (450-477)
Appendix L: Acknowledgements (478-480)
Appendix M: Biographical Sketches of Commitee Members (481-488)
Index (489-506)